Close Menu

In a study out of Michigan that seems to have overturned the cancer stem cell theory, researchers found that after introducing human melanoma cells into immunocompromised mice, many more than expected developed tumors. In the less immunocompromised mice, only one in 837,000 cells regenerated melanoma, while in the more vulnerable mice one in four cells did, says a related news story.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.